Infections with dengue virus have increased significantly over the past two decades and it is estimated that >3 billion people live in at-risk areas worldwide. Whitehead and colleagues discuss ...

MSD is preparing to take on Takeda in the dengue fever vaccine market, moving its V181 candidate into phase 3.